Skip to main content

Published locations for Inebilizumab ‘MITIGATES’ Flare Risk in IgG4-Related Disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Inebilizumab ‘MITIGATES’ Flare Risk in IgG4-Related Disease

User login

  • Reset your password
  • /content/inebilizumab-mitigates-flare-risk-igg4-related-disease
  • /internalmedicinenews/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare
  • /neurologyreviews/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare-risk
  • /rheumatologynews/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare-risk
  • /rheumatology/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare-risk-igg4
  • /internalmedicine/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare-risk
  • /neurology/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare-risk-igg4
  • /chestphysician/article/269498/lupus-connective-tissue-diseases/inebilizumab-mitigates-flare-risk